Medicare Enrolled
Dr. Shaachi Gupta, M.D.
Hematology · Palm Springs, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gupta
Dr. Shaachi Gupta is a hematology specialist in Palm Springs, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 83,261 Medicare services across 2,335 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gupta received a total of $20,263 from 98 pharmaceutical and/or device companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ 83,261 Medicare services
$20,263 industry payments
Medicare Practice Summary
Medicare Utilization ↗83,261
Medicare services
Bottom 48% in FL for hematology
2,335
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,626 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 14,790 | $0 | $4 |
| Iron sucrose injection (Venofer) | 13,000 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 10,790 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 9,900 | $0 | $2 |
| Daratumumab injection (Darzalex) | 9,360 | $38 | $110 |
| Paclitaxel chemotherapy injection | 7,497 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 3,640 | $0 | $1 |
| Dexamethasone injection (steroid) | 2,134 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 2,021 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 1,440 | $18 | $51 |
| Complete blood count (CBC) with differential | 1,357 | $8 | $29 |
| Blood draw (venipuncture) | 1,221 | $8 | $9 |
| Iron infusion (Monoferric) | 1,100 | $16 | $57 |
| Office visit, established patient (30-39 min) | 881 | $99 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 870 | $1 | $28 |
| Office visit, established patient (20-29 min) | 332 | $69 | $239 |
| Injection, carboplatin, 50 mg | 291 | $2 | $41 |
| Administration of chemotherapy into vein, 1 hour or less | 283 | $103 | $378 |
| Injection of additional new drug or substance into vein | 274 | $12 | $61 |
| Anti-nausea injection (ondansetron/Zofran) | 264 | $0 | $9 |
| Drug injection, under skin or into muscle | 251 | $11 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 203 | $23 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 157 | $49 | $189 |
| Injection, zoledronic acid, 1 mg | 155 | $6 | $69 |
| Administration of additional new drug or substance into vein, 1 hour or less | 116 | $52 | $178 |
| Injection, diphenhydramine hcl, up to 50 mg | 116 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 111 | $23 | $79 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 68 | $57 | $206 |
| Hospital follow-up visit, moderate complexity | 62 | $64 | $197 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 57 | $3 | $11 |
| New patient office visit (45-59 min) | 56 | $123 | $453 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 49 | $401 | $680 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 48 | $1,164 | $3,706 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 42 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 40 | $16 | $56 |
| Initial hospital admission, moderate complexity | 39 | $104 | $377 |
| Infusion into a vein for hydration, each additional hour | 35 | $10 | $42 |
| Ct scan of chest with contrast | 33 | $61 | $350 |
| Infusion, normal saline solution , 1000 cc | 31 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 27 | $25 | $156 |
| Injection of drug or substance into vein | 25 | $28 | $156 |
| CT scan of abdomen and pelvis with contrast | 24 | $180 | $564 |
| Automated urinalysis | 22 | $2 | $8 |
| Echocardiogram, transthoracic | 21 | $106 | $435 |
| New patient office visit (30-44 min) | 15 | $81 | $298 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $19 | $59 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.7% high complexity
75.3% medium
5.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,263
Total received (2018-2024)
Avg $2,895/year across 7 years
Top 22% in FL for hematology
98
Companies
977
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,297 (80.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,795 (8.9%)
Other
Charitable contributions, space rental, and other categories
$1,320 (6.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$851 (4.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,079
2023
$3,359
2022
$2,230
2021
$1,714
2020
$1,143
2019
$2,625
2018
$4,112
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$3,425
Janssen Biotech, Inc.
$1,715
Celgene Corporation
$1,284
AstraZeneca Pharmaceuticals LP
$905
PFIZER INC.
$808
Genentech USA, Inc.
$773
Merck Sharp & Dohme Corporation
$768
E.R. Squibb & Sons, L.L.C.
$737
Merck Sharp & Dohme LLC
$673
Amgen Inc.
$549
Daiichi Sankyo Inc.
$523
Eisai Inc.
$469
Takeda Pharmaceuticals U.S.A., Inc.
$435
Lilly USA, LLC
$380
Astellas Pharma US Inc
$372
GENZYME CORPORATION
$336
Incyte Corporation
$306
ABBVIE INC.
$299
GlaxoSmithKline, LLC.
$278
Pharmacyclics LLC, An AbbVie Company
$238
Puma Biotechnology, Inc.
$230
Seagen Inc.
$206
Bayer HealthCare Pharmaceuticals Inc.
$192
Ipsen Biopharmaceuticals, Inc
$182
Seattle Genetics, Inc.
$166
ARRAY BIOPHARMA INC
$164
Alexion Pharmaceuticals, Inc.
$141
Sun Pharmaceutical Industries Inc.
$138
Mirati Therapeutics, Inc.
$136
Boston Scientific Corporation
$122
EISAI INC.
$121
Exelixis Inc.
$119
EMD Serono, Inc.
$119
Gilead Sciences, Inc.
$116
Regeneron Healthcare Solutions, Inc.
$114
Karyopharm Therapeutics Inc.
$114
JAZZ PHARMACEUTICALS INC.
$113
SOBI, INC
$111
BeiGene USA, Inc.
$107
NOVARTIS PHARMACEUTICALS CORPORATION
$104
Lexicon Pharmaceuticals, Inc.
$94
Foundation Medicine, Inc.
$91
Pharmacyclics LLC, an AbbVie Company
$89
Abbott Laboratories
$84
Adaptive Biotechnologies Corporation
$82
AbbVie Inc.
$82
SERVIER PHARMACEUTICALS LLC
$72
Blueprint Medicines Corporation
$67
Dendreon Pharmaceuticals LLC
$66
Kite Pharma, Inc.
$63
Myriad Genetic Laboratories, Inc.
$60
Stemline Therapeutics Inc.
$55
TerSera Therapeutics LLC
$55
AbbVie, Inc.
$48
Kyowa Kirin, Inc.
$47
Teva Pharmaceuticals USA, Inc.
$47
Shield Therapeutics Inc
$47
Agios Pharmaceuticals, Inc.
$46
Clovis Oncology, Inc.
$46
Array BioPharma Inc.
$44
Spectrum Pharmaceuticals Inc.
$42
Genentech, Inc.
$38
Genmab U.S., Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$38
Rigel Pharmaceuticals, Inc.
$32
Medtronic, Inc.
$32
Geron Corporation
$31
Sirtex Medical Inc
$31
SpringWorks Therapeutics, Inc.
$30
Fennec Pharmaceuticals, Inc.
$30
Heron Therapeutics, Inc.
$28
MorphoSys, US Inc.
$28
Octapharma USA, Inc.
$28
Sobi, Inc
$27
BAXTER HEALTHCARE
$26
Global Blood Therapeutics, Inc.
$26
Deciphera Pharmaceuticals Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
Helsinn Therapeutics (U.S.), Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$22
TESARO, Inc.
$22
ADC Therapeutics America, Inc.
$22
Acrotech Biopharma LLC
$20
Cumberland Pharmaceuticals, Inc.
$19
G1 Therapeutics, Inc.
$19
Jazz Pharmaceuticals Inc.
$19
Mylan Institutional Inc.
$19
Secura Bio, Inc.
$17
Advanced Accelerator Applications
$15
West Therapeutics Development, LLC
$15
RECORDATI_RARE_DISEASES_INC.
$15
Verastem, Inc.
$14
Mylan Pharmaceuticals Inc.
$14
SECURA BIO, INC.
$13
Taiho Oncology, Inc.
$13
Dova Pharmaceuticals
$12
Aurobindo Pharma USA, Inc.
$12
INSYS Therapeutics Inc
$11
Top 3 companies account for 31.7% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · Aranesp · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FOUNDATIONONE · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAZYVA · HEMLIBRA · HYQVIA · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFUGEM · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Ogivri · Onivyde · OptiCross · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · Quadra Allure MP RF CRT Pacemkr · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SYLVANT · SYNDROS · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TISSEEL · TIVDAK · TUKYSA · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · VPRIV · Venclexta · Vitrakvi · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $24 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
11
Per 100K population
0.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gupta is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gupta experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gupta performed 14,790 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $20,263 from 98 companies across 977 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other hematologists in Palm Springs?
Dr. Gupta's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Palm Springs
Browse hematologists in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology